| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 246.861 | 86 |
| GSM780708 | Untreated after 4 days (C2_1) | 204.213 | 84 |
| GSM780709 | Untreated after 4 days (C3_1) | 170.616 | 82 |
| GSM780719 | Untreated after 4 days (C1_2) | 259.878 | 86 |
| GSM780720 | Untreated after 4 days (C2_2) | 190.165 | 83 |
| GSM780721 | Untreated after 4 days (C3_2) | 169.391 | 82 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 177.709 | 82 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 207.061 | 84 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 220.74 | 85 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 154.75 | 81 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 234.657 | 85 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 245.63 | 86 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 214.798 | 84 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 204.705 | 84 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 241.45 | 85 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 232.432 | 85 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 201.844 | 84 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 250.32 | 86 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 243.704 | 86 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 220.081 | 85 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 232.131 | 85 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 224.522 | 85 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 203.757 | 84 |